71 related articles for article (PubMed ID: 12622121)
1. New hepatitis treatment decreases injections.
AIDS Patient Care STDS; 2003 Jan; 17(1):46. PubMed ID: 12622121
[No Abstract] [Full Text] [Related]
2. Interferon-based therapy of hepatitis C.
Chevaliez S; Pawlotsky JM
Adv Drug Deliv Rev; 2007 Oct; 59(12):1222-41. PubMed ID: 17869375
[TBL] [Abstract][Full Text] [Related]
3. Novel interferons for treatment of hepatitis C virus.
Clark V; Nelson DR
Clin Liver Dis; 2009 Aug; 13(3):351-63. PubMed ID: 19628153
[TBL] [Abstract][Full Text] [Related]
4. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Post AB; Redfield RR; Davis GL; Neumann AU; Osborn BL; Freimuth WW; Subramanian GM
Antivir Ther; 2006; 11(1):35-45. PubMed ID: 16518958
[TBL] [Abstract][Full Text] [Related]
5. Viral kinetics in hepatitis C.
Lutchman G; Hoofnagle JH
Hepatology; 2003 Jun; 37(6):1257-9. PubMed ID: 12774002
[No Abstract] [Full Text] [Related]
6. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
Giostra E; Kullak-Ublick GA; Keller W; Fried R; Vanlemmens C; Kraehenbuhl S; Locher S; Egger HP; Clavien PA; Hadengue A; Mentha G; Morel P; Negro F
Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
[TBL] [Abstract][Full Text] [Related]
7. [Review of recent research on hepatitis C therapy for 54th annual meeting of the American association for the study of liver diseases].
Wei L
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):118-20. PubMed ID: 14980127
[No Abstract] [Full Text] [Related]
8. [What happens to the used equipment (needles, vials, syringes, pens) after interferon injection at home?].
Ouzan D; Collomp R; Mousnier A
Gastroenterol Clin Biol; 2000 Oct; 24(10):966-7. PubMed ID: 11084436
[No Abstract] [Full Text] [Related]
9. Drug evaluation: Albuferon-alpha--an antiviral interferon-alpha/albumin fusion protein.
Chemmanur AT; Wu GY
Curr Opin Investig Drugs; 2006 Aug; 7(8):750-8. PubMed ID: 16955687
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of viral hepatitis in children].
Kekez AJ
Acta Med Croatica; 2005; 59(5):463-7. PubMed ID: 16381244
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
[TBL] [Abstract][Full Text] [Related]
13. Anemia during treatment of hepatitis C in HIV-infected patients.
Lo Re V; Kostman JR
AIDS Read; 2004 Oct; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous ulceration induced by interferon alfa.
Gallelli L; Guadagnino V; Caroleo B; Marigliano N; De Sarro G
Ann Pharmacother; 2004 Jan; 38(1):173-4. PubMed ID: 14742818
[No Abstract] [Full Text] [Related]
15. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
Husa P
J Gastroenterol Hepatol; 2005 May; 20(5):669-70. PubMed ID: 15853976
[No Abstract] [Full Text] [Related]
16. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2008 Aug; 80(8):1363-9. PubMed ID: 18551610
[TBL] [Abstract][Full Text] [Related]
17. A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients.
Bain VG; Kaita KD; Yoshida EM; Swain MG; Heathcote EJ; Neumann AU; Fiscella M; Yu R; Osborn BL; Cronin PW; Freimuth WW; McHutchison JG; Subramanian GM
J Hepatol; 2006 Apr; 44(4):671-8. PubMed ID: 16487617
[TBL] [Abstract][Full Text] [Related]
18. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain.
Yachimski P; Chung RT
AIDS Read; 2004 Oct; 14(10):568-9. PubMed ID: 15510393
[No Abstract] [Full Text] [Related]
19. Retreatment of chronic hepatitis C virus infection.
Pardo M; Cotonat T; Herrero M; Marriott E; Artillo S; Quiroga JA; Carreño V
Lancet; 1994 Jun; 343(8912):1568-9. PubMed ID: 7911888
[No Abstract] [Full Text] [Related]
20. Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin.
Boulestin A; Sandres-Saune K; Alric L; Pipy B; Dubois M; Vinel JP; Izopet J
Antivir Ther; 2005; 10(4):499-504. PubMed ID: 16038475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
